These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11260277)

  • 1. Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations.
    Favaloro EJ
    Haemophilia; 2001 Mar; 7(2):170-9. PubMed ID: 11260277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of the PFA-100.
    Favaloro EJ
    Curr Opin Hematol; 2002 Sep; 9(5):407-15. PubMed ID: 12172459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of the PFA-100.
    Favaloro EJ
    Semin Thromb Hemost; 2008 Nov; 34(8):709-33. PubMed ID: 19214910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Jul; 32(5):537-45. PubMed ID: 16862528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of closure times using the platelet function analyzer-100/200.
    Favaloro EJ
    Am J Hematol; 2017 Apr; 92(4):398-404. PubMed ID: 27935090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The platelet function analyzer (PFA-100): an update on its clinical use.
    Franchini M
    Clin Lab; 2005; 51(7-8):367-72. PubMed ID: 16122146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies.
    Favaloro EJ; Kershaw G; Bukuya M; Hertzberg M; Koutts J
    Haemophilia; 2001 Mar; 7(2):180-9. PubMed ID: 11260278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet-function analyzer (PFA-100) for evaluating primary hemostasis.
    Franchini M
    Hematology; 2005 Jun; 10(3):177-81. PubMed ID: 16019466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the PFA-100 as a screening test of platelet function: an audit of haemostasis laboratories in Australia and New Zealand.
    Favaloro EJ; Bonar R; Duncan E; Rodgers S; Marsden K;
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):441-8. PubMed ID: 17581318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history-a systematic review and meta-analysis.
    Karger R; Donner-Banzhoff N; Müller HH; Kretschmer V; Hunink M
    Platelets; 2007 Jun; 18(4):249-60. PubMed ID: 17538845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
    Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
    Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PFA-100 test in the detection of platelet dysfunction and monitoring DDAVP in a patient with liver cirrhosis undergoing inguinal hernia repair.
    Vucelić D; Golubović M; Bjelović M
    Srp Arh Celok Lek; 2012; 140(11-12):782-5. PubMed ID: 23350257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ISTH bleeding assessment tool and platelet function analyzer in children with mild inherited platelet function disorders.
    Alhaj D; Hagedorn N; Cuntz F; Reschke M; Schuldes J; Ruthenberg J; Bakchoul T; Greinacher A; Holzhauer S
    Eur J Haematol; 2024 Jul; 113(1):54-65. PubMed ID: 38549165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.
    Quiroga T; Goycoolea M; Muñoz B; Morales M; Aranda E; Panes O; Pereira J; Mezzano D
    J Thromb Haemost; 2004 Jun; 2(6):892-8. PubMed ID: 15140124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update.
    Favaloro EJ; Bonar R
    Semin Thromb Hemost; 2014 Mar; 40(2):239-53. PubMed ID: 24497116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function.
    Hayward CP; Harrison P; Cattaneo M; Ortel TL; Rao AK;
    J Thromb Haemost; 2006 Feb; 4(2):312-9. PubMed ID: 16420557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
    Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
    Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.